Fifth Third Bancorp lifted its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 597.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 424,817 shares of the company’s stock after purchasing an additional 363,931 shares during the period. Fifth Third Bancorp’s holdings in Avantor were worth $3,331,000 as of its most recent filing with the SEC.
A number of other large investors also recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC boosted its position in Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after buying an additional 1,189 shares during the period. Strategic Wealth Investment Group LLC bought a new position in shares of Avantor during the second quarter valued at about $32,000. Private Trust Co. NA increased its holdings in shares of Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after buying an additional 875 shares during the period. Osaic Holdings Inc. increased its holdings in shares of Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the period. Finally, Los Angeles Capital Management LLC bought a new stake in shares of Avantor in the 4th quarter valued at about $32,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.
Insider Activity at Avantor
In other news, Director Gregory T. Lucier bought 10,000 shares of the firm’s stock in a transaction dated Friday, May 8th. The stock was purchased at an average price of $8.32 per share, with a total value of $83,200.00. Following the transaction, the director owned 60,000 shares of the company’s stock, valued at approximately $499,200. The trade was a 20.00% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Simon Dingemans bought 25,000 shares of the stock in a transaction dated Friday, May 1st. The stock was purchased at an average price of $8.14 per share, with a total value of $203,500.00. Following the purchase, the director owned 25,000 shares in the company, valued at $203,500. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 0.28% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on AVTR
Avantor Price Performance
Shares of Avantor stock opened at $11.06 on Monday. The company has a market cap of $7.55 billion, a PE ratio of -13.66, a P/E/G ratio of 6.16 and a beta of 0.94. The business has a 50 day moving average of $9.40 and a 200 day moving average of $9.41. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.
Avantor (NYSE:AVTR – Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The company’s quarterly revenue was up .0% compared to the same quarter last year. During the same period last year, the company posted $0.23 EPS. As a group, equities research analysts forecast that Avantor, Inc. will post 0.79 earnings per share for the current year.
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
See Also
- Five stocks we like better than Avantor
- Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
- Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
